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The tetracycline aptamer is an in vitro selected RNA
that binds to the antibiotic with the highest known
affinity of an artificial RNA for a small molecule
(Kd 0.8 nM). It is one of few aptamers known to be
capable of modulating gene expression in vivo. The
2.2 A˚ resolution cocrystal structure of the aptamer re-
veals a pseudoknot-like fold formed by tertiary inter-
actions between an 11 nucleotide loop and the minor
groove of an irregular helix. Tetracycline binds within
this interface as a magnesium ion chelate. The struc-
ture, together with previous biochemical and bio-
physical data, indicates that the aptamer undergoes
localized folding concomitant with tetracycline bind-
ing. The three-helix junction, h-shaped architecture
of this artificial RNA is more complex than those of
most aptamers and is reminiscent of the structures
of some natural riboswitches.
INTRODUCTION
Aptamers are artificially evolved RNAs selected in vitro to bind to
other molecules (Ellington and Szostak, 1990). Numerous ap-
tamers have been discovered that bind to ligands as diverse
as metal ions, small organic molecules, nucleic acids, and pro-
teins. Several of them have been characterized biochemically
and structurally (reviewed in Feigon et al., 1996; Hermann and
Patel, 2000; Wilson and Szostak, 1999). Aptamers that bind to
small organic molecules have been of interest both to elucidate
the structural basis of molecular recognition by RNA, and as part
of efforts to develop biotechnological tools such as affinity tags,
biosensors, and small-molecule responsive enzymes (Lorenz
and Schroeder, 2006). In recent years, it was discovered that ar-
chaea, bacteria, and eukarya employ highly structured mRNA
domains to bind directly to intracellular metabolites (reviewed
in Edwards et al., 2007). Binding of these noncoding mRNA do-
mains, called riboswitches, to their cognate effectors results in
a change in transcription, translation, or posttranscriptional pro-
cessing of the mRNA of which they are part. By analogy with the
in vitro selected RNAs, the moiety of a natural riboswitch thatChemistry & Biology 15, 1125–suffices for specific binding to its effector metabolite has been
referred to as its ‘‘aptamer domain.’’
The tetracycline aptamer was identified by Schroeder and co-
workers through in vitro selection from a pool of RNAs containing
74 nucleotides (nt) of random sequence (Berens et al., 2001).
RNAswere bound to an affinity columnwith immobilized tetracy-
cline, and molecules that were eluted specifically with tetracy-
cline were amplified and used in further rounds of selection.
Biochemical characterization of cb28, one of the resulting tetra-
cycline-binding RNAs, was used to guide the design of a 60 nt
‘‘cb28 minimer’’ (Berens et al., 2001). This compact tetracycline
aptamer was found to bind to its ligand with a dissociation con-
stant of0.8 nM, which is three orders of magnitude tighter than
binding of the antibiotic to the 30S subunit of the bacterial ribo-
some, tighter than any other known aptamer-small molecule
interaction (Mu¨ller et al., 2006), and similar to the tightest known
natural riboswitch-small molecule interaction (Welz and Breaker,
2007).
Previous crystallographic and NMR characterization of ap-
tamers that recognize small molecules has revealed a prepon-
derance of structures consisting of single helical stacks with an
irregularly structured segment that encapsulates the ligand at
the junction of two helices (Feigon et al., 1996; Hermann and
Patel, 2000; Wilson and Szostak, 1999). In contrast, the tetracy-
cline aptamer comprises three helices, one of which is closed by
a long loop. Chemical and enzymatic probing experiments sug-
gest that this stem-loop forms the antibiotic binding site by asso-
ciating with a distant segment that connects the other two
helices (Berens et al., 2001; Hanson et al., 2005). Such a binding
site, resulting from long-range (tertiary) contacts, would be dif-
ferent from those of most aptamers, but is reminiscent of theme-
tabolite binding sites of several naturally occurring riboswitches
(reviewed in Edwards et al., 2007). Indeed, Suess and coworkers
have successfully employed the tetracycline aptamer as an arti-
ficial riboswitch (reviewed in Suess and Weigand, 2008). By in-
troducing the aptamer into two introns of a yeast mRNA, they
achieved 32-fold tetracycline-mediated repression of gene ex-
pression in vivo (Weigand and Suess, 2007). This compares fa-
vorably with the best artificial riboswitches, and is within a factor
of three of some natural riboswitches (Lynch et al., 2007).
We have now determined the cocrystal structure of the cb28
minimer in order to elucidate the chemical underpinnings for
high-affinity and high-specificity binding of tetracycline by this1137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1125
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Tetracycline Recognition by an Artificial RNARNA. Our work also provides a structural framework for rational-
izing the considerable body of biochemical and biophysical
characterization previously carried out on this system, and
serves as a starting point in further engineering of this artificial ri-
boswitch. The structure lays bare the mechanism of tetracycline
recognition by this aptamer, and suggests the molecular nature
of a localized RNA conformational rearrangement that accom-
panies antibiotic binding. Moreover, because structures of tetra-
cycline bound to its antibacterial target, the 30S ribosome, as
well as to the tetracycline repressor (TetR) protein have previ-
ously been determined, we have been able to compare and con-
trast different ways in which RNAs and proteins recognize this
widely employed antibiotic.
RESULTS
Crystallization and Structure Determination
The cb28 minimer of Berens et al. (2001) comprises three heli-
ces, P1, P2, and P3, with loops P2 and P3 closing the distal
ends of the latter two (Figure 1A). In the course of minimizing
cb28, these authors replaced the original 16 nt closing the P2
helix with a UUCG tetraloop. Similarly, P1 resulted from deletion
of 19 residues. These and other analyses indicate that the distal
ends of P1 and P2 are functionally dispensable. In contrast, L3
was found to be essential for tetracycline binding (Berens
et al., 2001; Hanson et al., 2005). In order to facilitate crystalliza-
tion and structure determination, we generated circularly per-
muted aptamer constructs in which the distal end of P1 was
closed with the U1A binding site (Ferre´-D’Amare´ et al., 1998b),
and L2 was deleted (Figure 1B). The U1A complex of this per-
muted aptamer binds the antibiotic with an affinity that is compa-
rable to that of the wild-type aptamer (see Figure S1 available
online). As is conventional (Ferre´-D’Amare´ and Doudna, 2000b;
Ferre´-D’Amare´ et al., 1998a), we generated a panel of crystalliza-
tion candidate RNAs by varying the number of spacer base pairs
between the U1A binding site and P1, and the number and se-
quence of P2 terminal nucleotides. A circularly permuted 65 nt
tetracycline aptamer construct produced well-ordered cocrys-
tals when complexed with selenomethionyl U1A RNA-binding
domain (RBD) and 7-chlorotetracycline. Previously, it was shown
that presence of a chlorine at position 7 of tetracycline (Figure 1C)
slightly increases affinity of the antibiotic for the cb28 minimer
(Kd = 0.6 versus 0.8 nM; Mu¨ller et al., 2006). The structure was
solved by the multiwavelength anomalous dispersion (MAD)
method, and refined against diffraction data extending to 2.2 A˚
resolution. The current crystallographic model has a free R factor
of 26.3% and a mean precision of 0.2 A˚ (Table 1; Experimental
Procedures). The congruence of our structure of the circularly
permuted RNA with previous biochemical data on the tetracy-
cline aptamer (below) and the similarity in the affinity for the an-
tibiotic of the wild-type and permuted RNAs suggest that
engineering of the RNA construct for crystallization has not
drastically altered the mode of interaction of the aptamer and
antibiotic.
Overall Structure
The tetracycline aptamer fold resembles an inverted ‘‘h,’’ with
the antibiotic binding site at the junction of two helical stacks
(Figure 1; Figure S2). Helices P1 and P3, and loop L3 stack on1126 Chemistry & Biology 15, 1125–1137, October 20, 2008 ª2008each other. Helix P2 stacks on an irregular helix formed by asso-
ciation of joining regions J1/2 and J2/3. The three-dimensional
structure of the ligand-bound state of the aptamer results from
a series of tertiary interactions between the 11 nt L3 loop and
the minor groove face of the irregular helix. L3 nucleotides
55–57 form nonstandard pairs with nucleotides from J1/2 and
J2/3. Thus, the fold of the aptamer comprises a noncanonical
pseudoknot (a canonical pseudoknot results fromWatson-Crick
pairing of nucleotides from the loop of a stem-loop and nucleo-
tides outside the stem-loop; Pleij, 1990). In addition to tertiary
RNA interactions, the structure appears to be stabilized by the
bound antibiotic, a series of tightly bound divalent cations, and
a network of ordered water molecules.
The core of the aptamer structure is formed by an irregular tri-
plex (Figures 2A and 2B) resulting from close apposition of J1/2,
J2/3, and three L3 nucleotides. In this region of the RNA, the
backbones of J2/3 and L3 run in the same direction, whereas
J1/2 is antiparallel. At the transition from P1 (gray in Figures 1E
and 2) to J1/2 (magenta), the RNA chain makes an abrupt turn,
such that whereas residue 6 at the top of helix P1 is in a standard
A-form helical environment, residue 7 is nearly perpendicular,
and one face of its adenine base is completely unstacked and
solvent exposed (Figures 1D and 2A). Neither A7 nor A8 partici-
pate in base pairing, but they stack underneath the helical stack
of residues from J2/3, which is running with the opposite polarity
(Figures 2A and 2B). Like A7, A9 is unstacked on its bottom face,
and forms part of a coplanar base triple. It makes a cis Hoogs-
teen edge to Watson-Crick base pair with A44, and simulta-
neously makes a trans Watson-Crick pair with A55. The trans
orientation of this pair results from the parallel direction of the
backbones of A9 and A55. This base triple stacks on a transWat-
son-Crick pair formed by C10 and C56. The two cytosine bases
share three hydrogen bonds, with their N3 groups separated by
2.6 A˚. This implies that these imine nitrogen atoms are partially
protonated.
Close packing of the aptamer core is facilitated by interdigita-
tion of G57 from L3 between G43 and A44 of J2/3 (Figure 2B).
G57 stacks between these two bases, and also makes a hydro-
gen bond to a nonbridging phosphate oxygen of A44. In turn,
G43 makes a ribose zipper-type interaction between its 20-OH
and the N3 and 20-OH of G57. A11 from J1/2 protrudes deeply
into the minor groove, and its N1 hydrogen bonds to the 20-OH
of C56. The Hoogsteen face of G57 makes one hydrogen bond
each with the bases of C10 (thus forming a second base triple)
and A11. This bifurcated base pairing and the interdigitation to-
gether have the result that the triplex comprises five nucleotides
in the continuous J1/2 strand (A9–A13) and only four in the oppo-
site composite strand (A42–A44 from J2/3, and G57 from L3).
Toward the 30 end of J1/2, theminor groove is stretched by a sin-
gle-hydrogen-bond base pair formed between U12 and G43.
This pair appears to be stabilized in addition by a water-medi-
ated Watson-Crick face interaction. Finally, A13 and A42 share
a single hydrogen bond between their Watson-Crick faces.
The base of the L3 loop is closed by a single-hydrogen-bond
pair between A49 and C59 (their N1 and N4 atoms, respectively,
are 2.8 A˚ apart; Figure 2A). A50 and A58 stack on this pair, but
they are too distant from each other to hydrogen bond (their clos-
est approach, between N3 of A50 andN6 of A58, is 4.1 A˚). Nucle-
otides G51 and A52 stack on each other and on the 50 side of theElsevier Ltd All rights reserved
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Tetracycline Recognition by an Artificial RNAFigure 1. Overall Structure of the Tetracycline Aptamer
(A) Sequence of a wild-type connectivity tetracycline aptamer. Residue numbers correspond to those of the constructs of Hanson et al. (2005) and Mu¨ller et al.
(2006). Gray nucleotides are functionally dispensable.
(B) Sequence of the circularly permuted crystallization construct. Note deletion of loop L2, and introduction of a U1A protein binding site capping paired region P1.
(C) Chemical structure of tetracycline, numbered conventionally. X is hydrogen or chlorine, for tetracycline and 7-chlorotetracycline, respectively.
(D) Schematic secondary structure of the tetracycline-bound conformation of the aptamer. Nucleotides that form the antibiotic binding site are boxed in green.
Thin lines with embedded arrowheads depict connectivity. Watson-Crick and single-hydrogen-bond pairs are indicated by thin and dashed lines, respectively.
Noncanonical base-pair symbols are those of Leontis andWesthof (2001). Asterisk indicates that the base of G57makes single hydrogen bonds with the bases of
both C10 and A11.
(E) Cartoon representation of the tetracycline aptamer (color coded as in [D]) in complex with 7-chlorotetracycline (green stick figure) and U1A. Selected well-
ordered magnesium ions and their solvation waters (magenta and red spheres, respectively) are shown. Colored arrows denote chain direction.loop in a manner not dissimilar from that seen in GNRA tetra-
loops (Figure 2C). However, the next two nucleotides adopt
atypical conformations. A53 is unstacked and projects towardChemistry & Biology 15, 1125–1the back of the loop. The base of U54 packs against the loop
from the rear, and hydrogen bonds to the base and to the sugar
of G51. This is made possible by a pronounced C30-exo137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1127
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Tetracycline Recognition by an Artificial RNApuckering of the ribose of U54. The next three nucleotides pro-
ject away from L3 and form part of the core triplex, as described
above. The peculiar conformation of L3 is facilitated by a series
of direct and water-mediated hydrogen bonds, as well as mag-
nesium ion coordination (Figure 2C).
Tetracycline Binding Pocket
Binding to the aptamer buries 425 A˚2 out of the 621 A˚2 total sol-
vent-accessible surface area of 7-chlorotetracycline. The bind-
ing site is formed by the minor grooves of L3 and the J1/2 and
J2/3 helix. As has previously been observed in its complexes
with the 30S ribosomal subunit (Brodersen et al., 2000) and
Table 1. Crystallographic Statistics
Remote Inflection Peak
Diffraction Data
Wavelength (A˚) 0.9570 0.9797 0.9795
Resolution (A˚)a 30.02.2
(2.32.2)
30.02.3
(2.42.3)
302.5
(2.62.5)
Rmerge (%)
a 8.0 (53.2) 7.4 (55.1) 7.8 (56.2)
< I >/< s(I) >a 37.6 (3.8) 36.6 (3.8) 36.4 (4.1)
Completeness (%)a 99.1 (99.9) 99.1 (99.8) 98.9 (99.7)
Redundancya 9.5 (9.8) 9.5 (9.7) 9.5 (9.7)
Phasing
Phasing power
Iso (acentrics) n/a 3.56 2.90
Ano (acentrics) 1.38 3.78 3.29
Rcullis (%) Ano 72.6 49.4 45.6
Mean overall
figure of merit
0.53
Refinement
Number of reflectionsb 19,015 (2,156)
Rwork/Rfree (%) 21.6/26.3
Number of atoms
RNA 1,380
Protein 728
7-Cl-tetracycline 33
Ion 12
Water 146
Mean B factors (A˚2)
RNA 52.5
Protein 42.2
7-Cl-tetracycline 68.5
Ion 61.3
Water 48.4
Root-mean-square deviations
Bond lengths (A˚) 0.012
Bond angles () 1.963
REFMAC coordinate 0.24 (0.21)
Precision (A˚)b
PDB ID code 3EGZ
n/a, not applicable.
a Values in parentheses are for the highest resolution shell.
b Values in parentheses are for the crossvalidation set.1128 Chemistry & Biology 15, 1125–1137, October 20, 2008 ª2008with the TetR protein (Hinrichs et al., 1994), the antibiotic binds
to the aptamer RNA as a magnesium ion chelate. The ketoeno-
late oxygens at positions 11 and 12 of tetracycline (Figure 1C)
provide two of the six inner-sphere ligands of the octahedrally
coordinated magnesium ion. The ketoenolate face of chlorote-
tracycline is deeply buried in the RNA. In contrast, the edge of
the antibiotic that bears the dimethylamine group (position 4)
and the chlorine (position 7) is exposed to solvent (Figures 3A
and 3B).
The tetracycline aptamer recognizes its ligand employing a va-
riety of interactions. The a (lower, in the views in Figure 3) face of
the conjugated rings C and D of the antibiotic (Figure 1C) stacks
on the purine base of A58. The strongest feature in the unbiased
residual electron density map (Figure 3C) is the deeply buried
magnesium ion coordinated to the antibiotic. In addition to the
two oxygen ligands provided by 7-chlorotetracycline, the metal
ion makes an inner-sphere coordination with the pro-RP non-
bridging phosphate oxygen of G57. Two water molecules that
make additional inner-sphere coordinations with the magnesium
ion are clearly visible. At the current resolution limit, there is no
electron density for the sixth ligand, but space is present in the
binding pocket for a third water molecule to occupy this axial po-
sition on the b side of tetracycline. A50 and A58 indirectly recog-
nize the magnesium ion by making three hydrogen bonds to two
of its coordinationwaters. In addition, the exocyclic amine of A50
appears to stabilize the backbone of G57 by making a water-
mediated hydrogen bond with its pro-SP phosphate oxygen.
RNA bases do not stack on the upper (b) face of the antibiotic.
Instead, A13 makes three hydrogen bonds with functional
groups on this face. The N3 and 20-OH of the nucleotide both hy-
drogen bond to the 6b-OH group of tetracycline, and its O40 ri-
bose oxygen makes a hydrogen bond with the nitrogen of the
amide group of the antibiotic. This amide group is also in van
der Waals contact with the base of U54 (Figures 3B and 3C).
RNA Hydration and Counterions
A prominent feature of the tetracycline binding site of the ap-
tamer is the presence of numerous well-ordered water mole-
cules directly below the antibiotic in the major groove of L3
(Figure 4A; Figure S3). These waters have crystallographic B fac-
tors comparable to those of the RNA atoms. At the current reso-
lution (2.2 A˚), the number of crystallographically observed water
molecules is most likely an underestimate of the waters trapped
in the major groove. There are additional ordered water mole-
cules in the major groove of L3 above the antibiotic. Thus, de-
spite the large fraction of its surface area buried by the RNA,
the antibiotic is bound in hydrated form.
The L3 major groove waters delineate a continuous path lead-
ing from the a face of the antibiotic to an entry at the junction of
the major grooves of P3 and the constriction formed by the close
approach of the backbones of J1/2 and J2/3. Three particularly
well ordered magnesium ions lie across this portal (Figure 4B;
Figure S3). The first of these (marked * in Figure 4) is fully hy-
drated, and makes at least eight hydrogen bonds to the RNA
through its inner-sphere, octahedrally coordinated water mole-
cules. Additional hydrogen bonds to the RNA through outer-
sphere coordination water molecules are also present. Two
partially desolvated magnesium ions track the narrow groove
formed by the closely apposed backbones of J1/2 and J2/3.Elsevier Ltd All rights reserved
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Tetracycline Recognition by an Artificial RNAChemistry & Biology 15, 1125–1Onemakes one inner-sphere coordination with the pro-SP phos-
phate of A44, while the other makes inner-sphere coordinations
with the pro-SP phosphate of A7 and the pro-RP phosphate of
A8. Both of these magnesium ions have octahedral coordination
geometry, but one of the ligands of each (presumably water) is
invisible in our current electron density maps.
DISCUSSION
Tetracycline Recognition
Studies in the Schroeder (Berens et al., 2001) and Suess (Mu¨ller
et al., 2006) laboratories using tetracycline analogs demon-
strated that the aptamer requires the hydroxyl group at position
6b of the antibiotic for binding. Thus, doxycycline (5-[a]-hydroxy-
6-[b]-deoxytetracycline) binds the RNA with 150-fold lower affin-
ity. This is not due to the 5-OH group present in doxycycline but
absent from tetracycline, because the affinity of 5-(a)-hydroxyte-
tracycline for the aptamer is only 2.3-fold lower than that of tet-
racycline. Our structure shows that 6b-OH is recognized through
two hydrogen bonds by A13, whereas the 5 position of tetracy-
cline points away from the binding pocket (Figure 3). The interac-
tion of A13 with the 6b-OH of tetracycline was predicted through
a thermodynamic double-cycle analysis (Mu¨ller et al., 2006). Our
structure elucidates the precise nature of this intermolecular in-
teraction. In our structure, A13 makes another hydrogen bond
with tetracycline: with its ribose O40 to the nitrogen of the amide
group at position 2 of tetracycline. Consistent with the impor-
tance of this interaction, Mu¨ller et al. (2006) found that 2-nitrilote-
tracycline bound the aptamer with 13-fold reduced affinity.
Tetracycline binds to the aptamer by stacking its rings C and D
on the purine base of A58. Ring D is aromatic and planar,
whereas ring C is not. Indeed, the critical hydroxyl group at po-
sition 6 projects above the plane of the ring. Mu¨ller et al. (2006)
found that anhydrotetracycline, which has an aromatic ring C re-
sulting from loss of the critical 6b-OH and an adjacent hydrogen,
bound the aptamer only 4.5 times more weakly than the parental
compound. This suggests that for this compound, loss of the hy-
drogen bonds made by the 6b-OH with A13 is compensated for
by improved stacking with A58, due to a planar ring C and the
methyl group at position 6 now being on the plane of rings C
andD.Conversely, 6-deoxy-6-demethyl tetracycline (sancycline),
which lacks both substituents at position 6 but retains the nonpla-
nar ringC, bound the aptamer 29 timesmoreweakly than tetracy-
cline (Mu¨ller et al., 2006). The dimethylamine group at position 4a
of tetracycline projects out of the binding pocket (Figure 3A). Not
surprising, its replacement with hydrogen results in only 2.6-fold
loss of affinity (Mu¨ller et al., 2006). Remarkably, combination
of the loss of the dimethylamine and the 6b-OH (in the form of
4-de-[dimethylamino]-5-hydroxy-6-deoxytetracycline) results in
Figure 2. Structure of the Aptamer Core
(A) Interaction of L3 with the minor groove of the irregular helix formed by J1/2
and J2/3. Two-headed arrows denote selected hydrogen bonds.
(B) Structure of the core triplex. View is approximately perpendicular to that
of (A).
(C) Detail of the top of L3. A well-ordered cation with two crystallographically
resolved coordination waters and a water molecule bridging N3 of A52 and
20-OH of U54 are shown. View is approximately that of (A).
Color coding as in Figure 1.137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1129
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2006). This loss in affinity, which is considerably larger than that
resulting from the loss of either the dimethylamine or the 6b-
OH, suggests that this small molecule adopts a mode of binding
distinctly different from that of the parental compound.
Tetracycline Binding-Induced RNA Structure
Hanson et al. (2005) extended the initial Pb2+ and DMSmodifica-
tion analyses of cb28 (Berens et al., 2001) by carrying out mod-
ification experiments using DMS, DEPC, CMCT, and kethoxal.
These reagents probe for the exposure of nucleotide bases to
bulk solution (reviewed in Brunel and Romby, 2000). A summary
of the results obtained by Hanson et al. (2005) upon probing the
tetracycline aptamer in the absence of the antibiotic are plotted
on the RNA structure in Figure 5A. Excluding the modification at
the distal end of P1 (due presumably to fraying of the helix), the
sites of strong or intermediate modification are at the tip of L3,
and in J1/2 and J2/3. Nucleotides G51, A52, and U54 of L3 are
the most strongly modified positions. The high reactivity of the
two purines is consistent with our cocrystal structure
(Figure 2C), but not the reactivity of U54, because in the liganded
structure of the RNA the uracil base is sequestered inside the L3.
Thus, it appears that in the absence of the antibiotic, L3 is poorly
folded. Nucleotides A7, A8, and A9 on one end of the triplex, and
A42 and U12 on the other (cf. Figure 2B), display intermediate
levels of modification. A7 and A8 are unpaired in our cocrystal
structure, so their susceptibility to modification is expected.
However, A9, U12, and A42 all participate in forming the triplex.
Therefore, these results suggest that the core triplex of the ap-
tamer is partially unfolded in the absence of antibiotic.
The change in susceptibility to modification of aptamer nucle-
otides by the same set of reagents between the free and tetracy-
cline-bound states determined by Hanson et al. (2005) is plotted
on the structure in Figure 5B. The largest changes occur in L3.
Nucleotides A49, A50, G51, and U54 become markedly more
protected upon tetracycline binding. This is consistent with L3
adopting the conformation displayed in our cocrystal structure,
where U54 makes a bidentate interaction with the sugar (minor
groove) edge of G51 (Figure 3C). The bases of A49 and A50 ex-
tend the 50 strand of P3 by stacking on it (Figures 2A and 2C).
G51 has been shown to crosslink to tetracycline when the
complex is subjected to UV irradiation (Berens et al., 2001). As
expected from its location directly underneath the bound
tetracycline, nucleotide A58 becomes strongly protected. A55
and G57 from L3, both of which participate in formation of the
core triplex, become moderately and strongly protected,
Figure 3. Structure of the Tetracycline Binding Site
(A) Solvent-accessible surface of the aptamer colored by curvature (green and
gray are convex and concave, respectively) with amolecular surface represen-
tation of the bound 7-chlorotetracycline. In this panel only, carbon atoms of the
antibiotic are drawn in black. Inset: ball-and-stick figure of the antibiotic and its
coordinated, hydrated magnesium ion in the same orientation as in the surface
representation. Note complete occlusion of the hydroxyl group at position 6b
in the aptamer complex.
(B) Detail of the binding site.
(C) View of the binding site from the direction of L3, superimposed on the
unbiased residual jFoj  jFcj electron density into which the antibiotic-magne-
sium complex was built, contoured at 3 and 5 SD (gray and red mesh, respec-
tively).Elsevier Ltd All rights reserved
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Tetracycline Recognition by an Artificial RNAFigure 4. Water Molecules and Hydrated Magnesium Ions in the Aptamer-Tetracycline Complex
(A) Well-ordered water molecules fill the major groove of L3 linking the exterior of the complex with the a face of the antibiotic. View is from the rear of Figure 1D.
(B) Magnesium ions line the junction between the major groove of P3 and the backbones of J1/2 and J2/3.
Asterisks denote the same magnesium ion. Although all three magnesium ions have octahedral coordination geometry, only the crystallographically resolved
ligands are shown.respectively, in the presence of antibiotic. Four other nucleotides
that form the core triplex, A9, U12, A13, and G43, also become
moderately protected upon ligand binding. Although DMS is
known to modify the N3 position of C (Brunel and Romby,
2000), neither C10 nor C56, which base pair with each other (Fig-
ures 2A, 2B, and 5C), aremodified (Figures 5A and 5B). Because,
in addition, these two cytosines are completely intolerant to mu-
tation (Hanson et al., 2005), it appears that their Watson-Crick
faces are engaged in base pairing even in the unbound aptamer.
In summary, the modification experiments show asymmetry in
that L3 nucleotides become strongly protected, whereas nucle-
otides of the irregular J1/2-J2/3 duplex become only moderately
protected. Because the tetracycline binding pocket forms by as-
sociation of L3 and the irregular duplex, this asymmetry in the
degree of protection is striking. This is especially so in comparing
the strong protection of G57, which interdigitates with nucleo-
tides from J2/3 that are not as strongly protected.
Our cocrystal structure suggests the specific molecular nature
of a tetracycline binding-induced rearrangement of the aptamer
RNA that was initially proposed from biochemical probing stud-
ies (Berens et al., 2001; Hanson et al., 2005) and later elaborated
on the basis of combinedmutational and calorimetric analysis by
Mu¨ller et al. (2006). The latter authors found that tetracycline
binding to the cb28 minimer is strongly enthalpically driven
(Kd = 0.77 nM; DH = 22.9 kcal/mol; TDS = 10.5 kcal/mol).
The A13U aptamer mutant bound tetracycline with a Kd of
222 nM. As would be expected from the multiple hydrogen
bonds made between this nucleotide and the antibiotic in our
structure, Mu¨ller et al. (2006) found that the loss in free energy
of binding was primarily due to a decrease in favorable enthalpy
(DH = 20.1 kcal/mol; TDS = 11.0 kcal/mol). Our structure in-
dicates that whereas a free U residue would be able to make
the same interactions with the antibiotic as an A (with the O4 of
U substituting for the hydrogen bond accepting N3 of A), as
part of the RNA chain, a uridine would be unable to reach theChemistry & Biology 15, 1125–Watson-Crick face of A42 (Figure 2B) and at the same time
bind the antibiotic. The A50U mutant suffers a comparable loss
in free energy of binding (Kd = 196 nM) but its thermodynamic
signature is completely different. For this mutant, DH was found
to be10.2 kcal/mol andTDSwas 1.0 kcal/mol; that is, the en-
thalpy of binding decreased dramatically, whereas the entropy of
binding becamemuchmore favorable. The structure of the com-
plex shows that the adenine base of A50 recognizes the magne-
sium ion that coordinates the tetracycline, and also helps posi-
tion RNA residues that interact with the antibiotic-metal ion
chelate (Figure 3C). A50 also stacks on top of the 50-helical stack
of P3. A uridine would be unable to make all these interactions,
and this presumably leads to the decrease in favorable enthalpy
of binding. On the other hand, the more favorable entropy of
binding suggests that in the A50U mutant, the antibiotic does
not interact with L3, which does not suffer losses in its degrees
of freedom. A binding mechanism in which the L3 side of the
tetracycline pocket undergoes considerable ordering but the
J1/2-J2/3 side is partially pre-organized would be consistent
with these experiments, and with the asymmetric decrease in
solvent exposure noted above.
Structural Basis of Tetracycline Binding
Regression analysis of the free energy of RNA-small molecule in-
teraction as a function of the burial of solvent-accessible surface
area demonstrated a linear relationship of 19 cal/mol per A˚2
(Edwards et al., 2007). This relationship is analogous to that
noted for protein interfaces (Eisenberg and McLachlan, 1986),
and is remarkable in that it holds across RNAs of a wide range
of sizes and distinctly different structures. Prominent exceptions
to this linear trend were the RNAs, both natural and artificial, that
bind to simple purines. The affinities of these RNAs for their li-
gands were too high to be accounted for exclusively by burial
of solvent-accessible surface area. Because the purine-binding
riboswitches completely envelop their cognate ligands, their1137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1131
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that occur only concomitant with ligand binding.
The solvent-accessible area of tetracycline buried by binding
to the cb28 minimer (425 A˚2) is insufficient to account for its sub-
nanomolar dissociation constant. Ultimately, structural charac-
terization of the unbound aptamer will be required to describe
fully themolecular basis of tetracycline recognition. Nonetheless,
our complex structure and previous biochemical studies suggest
that, in addition to L3 folding, formation of the intricate J1/2-J2/3
duplex contributes to the energetics of binding. A9 is the central
nucleotide of the base triple formed between A55, A9, and A44
(Figure 2A). Its mutation to G results in impaired binding to tetra-
cycline (Kd = 162 nM), an enthalpy of bindingmore favorable, and
an entropy of binding even more unfavorable, than for the wild-
type (DH = 28.4 kcal/mol; TDS = 19.7 kcal/mol). In contrast,
mutation to G of A55, the third member of the base triple, mini-
mally perturbs the affinity (Kd = 1.7 nM) or the enthalpically driven
nature of binding (DH = 21.8 kcal/mol; TDS = 10.6 kcal/mol)
(Mu¨ller et al., 2006). The discrepancy in the effects of mutation
of A9 or A55 is consistent with the J1/2-J2/3 duplex being par-
tially prestructured. We suggest that reorganization of the former
(induced by the A9G mutation) is entropically costly, whereas
rearrangement of the precise interaction between the duplex
and L3 (resulting from the A55G mutation) is not (compared
to wild-type), because L3 folding and tetracycline binding are
concomitant.
Solvent and ion fixation concomitant with RNA folding and tet-
racycline binding is evident in our cocrystal structure (Figure 4).
The presence of highly ordered water networks in the interior
of complexes of aptamers or riboswitches with their cognate li-
gands has been documented. For instance, the structure of the
vitamin B12 aptamer-ligand complex shows evidence of water
molecules that help stabilize noncanonical base pairing and
facilitate burial of highly polarized molecular moieties (Sussman
and Wilson, 2000). Thermodynamic analysis of hypoxanthine
binding by the guanine riboswitch (Batey et al., 2004) demon-
strated a highly enthalpically driven process (at 1.0 mM MgCl2,
Kd = 3 mM, DH = 35.4 kcal/mol, and TDS = 27.6 kcal/mol).
Crystallographic analysis of the riboswitch revealed that
whereas the purine ligand is completely enclosed in the RNA, it
remains partially solvated. Gilbert et al. (2006) proposed that
the ability of the purine riboswitch to discriminate between
closely related nucleobases rests on a strong dependence on
hydrogen bonding, rather than base stacking, with the ligand.
By surrounding the bound purine with water molecules, the
Figure 5. Biochemical Evidence for Tetracycline Binding-Induced
Aptamer Reorganization
(A) Results of chemical probing of the unliganded aptamer by Hanson et al.
(2005) plotted on the cocrystal structure. Dark, medium, and light blue denote
most strongly, intermediate, and most weakly modified nucleotides, respec-
tively.
(B) Magnitude of the change in chemical modification between the unliganded
and liganded tetracycline aptamer, determined by Hanson et al. (2005) plotted
on the crystal structure. Nucleotides with the largest changes are denoted by
deep purple, intermediate changes by magenta, and smallest by pink.
(C) Portion of the experimental electron density (Fourier synthesis calculated
with the density-modified MAD phases) corresponding to the C10C56 trans
Watson-Crick pair contoured at 1 and 3 SD (blue and green mesh, respec-
tively) superimposed on the final crystallographic model.Elsevier Ltd All rights reserved
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its specificity. Our structure shows that in the case of the cb28-
tetracycline interaction, stacking interactions are not the prepon-
derant mechanism of recognition. Rather, the binding site is hy-
drated, and hydrogen bonding, for instance with the 6b-OH of
tetracycline, is employed, allowing the RNA to achieve a high de-
gree of selectivity.
Comparison with Other Tetracycline Binding Sites
An important motivation for the in vitro selection of aptamers
against antibiotics is the elucidation of the range of molecular
recognition strategies available to RNA (Lorenz and Schroeder,
2006). Comparison of our structure with the binding sites for tet-
racycline of the 30S subunit of the bacterial ribosome (Brodersen
et al., 2000; Pioletti et al., 2001), TetR (Hinrichs et al., 1994), and
elongation factor Tu (EF-Tu) (Heffron et al., 2006) shows that al-
though all of these macromolecules recognize the magnesium
ion chelate of the antibiotic, the specific combination of macro-
molecule-antibiotic interactions each employs is unique.
Tetracycline has a Kd of1 mM for the bacterial ribosome, and
biochemical studies have mapped a functionally important bind-
ing site to the A site of the small subunit (Maxwell, 1967; Moazed
and Noller, 1987). Several tetracycline binding sites are present
in crystal structures of the tetracycline-bound 30S ribosomal
subunit (Brodersen et al., 2000; Pioletti et al., 2001). The site of
highest occupancy is at the A site, and is composed exclusively
of ribosomal RNA (Figure 6A). The antibiotic is recognized pri-
marily through its ketoenolate face through interactions with
nonbridging phosphate oxygens and ribose 20-OH groups. Al-
though the hydration waters of the chelated magnesium ion
are not resolved crystallographically, it appears that the ribo-
some also employs outer-sphere coordination to recognize the
metal ion. Unlike the aptamer, which stacks with rings C and D
of the antibiotic, the only stacking interaction in the primary
site of the 30S subunit is a modest interaction with C1054. Inter-
estingly, the 6b-OH that is critical for binding by the aptamer pro-
jects away from the rRNA. Indeed, there are no interactions
between the ribosome and that face of the antibiotic, other
than a possible electrostatic interaction between the tetracycline
dimethylamine and the G966 phosphate. This sparse set of inter-
actions is consistent with the comparatively low affinity of tetra-
cycline binding to the ribosome.
Resistance to tetracycline by Gram-negative bacteria primar-
ily results fromexport of the drug by an antiporter, TetA. The TetR
protein regulates expression of TetA at the transcriptional level
by releasing its operator when it binds the antibiotic. TetR is a di-
meric DNA-binding protein in which the tetracycline binding site
allosterically controls the orientation of the helix-turn-helix motif.
Consistent with the high affinity (Kd 1 nM) of TetR for its ligand
(Takahashi et al., 1986), the protein completely envelops the an-
tibiotic (Hinrichs et al., 1994; Kisker et al., 1995). The chelated
magnesium ion makes an inner-sphere coordination with
His100 from one protomer, and Glu1470 from the other subunit
makes a bidentate outer-sphere interaction with two of the coor-
dination waters of the metal ion (Figure 6B). Multiple hydropho-
bic side chains, including those of Arg104, Pro105, Leu131, Ile
134, and Leu1740, pack against ring D. TetR employs a polar-
aromatic interaction (Burley and Petsko, 1988) between Phe86
and the tetracycline OH group at the junction of rings A and B.Chemistry & Biology 15, 1125–Finally, TetR makes an intricate network of hydrogen bonds
with the polar groups that decorate ring A of the antibiotic, using
side chains such as those of His64 and Asn82.
Both TetR and cb28 have an absolute requirement forMg2+ for
binding to the antibiotic. This stems from recognition of themetal
ion chelate of the antibiotic by both macromolecules, and the
need for counterions for folding of the RNA. Although inner-
sphere coordination with the magnesium ion (through His100
and the nonbridging phosphate oxygen of G57 for TetR and
the aptamer, respectively) is highly favorable, making this inter-
action in aqueous solution requires desolvation of the ion. There-
fore, the net free energy gain from these interactions is likely
modest (Draper, 2004). Outer-sphere interactions, on the other
hand, need not overcome the enthalphy of solvation of Mg2+
and, if multidentate, have the additional entropic advantage
stemming from the chelate effect. Both macromolecular com-
plexes display this type of interaction (Glu1470 and A58 for
TetR and the aptamer, respectively). Beyond the expected dif-
ferences between a protein and an RNA, there are several note-
worthy differences between the specific tetracycline features
recognized by these two molecules. One is that the orientation
of the antibiotic relative to the binding site is approximately re-
versed: ring A of tetracycline is most deeply buried in TetR,
whereas it is partially solvent exposed in the aptamer. Another
is that whereas the 6b-OH of tetracycline is essential for recog-
nition by the aptamer, it is in fact detrimental for TetR-tetracy-
cline interaction. Indeed, the side chain of Val113 clashes with
this hydroxyl group (Hinrichs et al., 1994), and its removal results
in 35-fold tighter binding to the protein (Degenkolb et al., 1991).
Riboswitch Function of the Tetracycline Aptamer
The discovery of riboswitches has given new impetus to the de-
sign of their artificial counterparts: RNAs that enable small-
molecule control of gene expression in vivo. Although many
aptamers to small molecules have been selected in vitro, only
a handful have been found to function in vivo (reviewed in Suess
and Weigand, 2008). Indeed, in vivo selection experiments sug-
gest that features required for function within cells are underrep-
resented among aptamers, and an approach that combines
in vitro selection to obtain aptamers and in vivo selection for
gene-regulatory function offers promise. Unlike the neomycin
(Weigand et al., 2008) and theophylline (Lynch et al., 2007) ap-
tamers, which had to be optimized by in vivo selection to function
efficiently, the tetracycline aptamer achieved control of gene
expression essentially in its original form (Hanson et al., 2003;
Suess et al., 2003; Weigand and Suess, 2007).
What are the molecular correlates of the ability of the tetracy-
cline aptamer to function in vivo? There are three features of the
tetracycline aptamer that are reminiscent of natural ribos-
witches. First, the affinity of the tetracycline riboswitch for its
cognate ligand is comparable to that of the most stable natural
riboswitch-effector interaction. Presumably, the affinities of nat-
ural riboswitches are tuned to the intracellular concentration of
their effectors. Thus, the high affinity of cb28 for tetracycline, al-
though important (Hanson et al., 2005; Mu¨ller et al., 2006), is un-
likely to be key to its in vivo function. (Because of the difference in
translation initiation mechanisms between eukaryotes and bac-
teria, it is possible that high affinity is more important in eukary-
otes. However, the tetracycline aptamer cannot be tested in1137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1133
Chemistry & Biology
Tetracycline Recognition by an Artificial RNAFigure 6. Comparison of Ribosomal and
Protein Tetracycline Binding Sites
(A) Detail of the primary tetracycline binding site in
the 3.4 A˚ resolution cocrystal structure of the 30S
ribosomal subunit of Thermus thermophilus
(Brodersen et al., 2000).
(B) Detail of the ligand binding site of the 2.1 A˚ res-
olution structure of the complex between the class
D tetracycline repressor protein (TetR) and
7-chlorotetracycline (Hinrichs et al., 1994; Kisker
et al., 1995). The binding site is formed by amino
acid residues from both protomers of the dimeric
protein. Amino acid residues from the second pro-
tomer are colored magenta.1134 Chemistry & Biology 15, 1125–1137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved
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natural riboswitches such as the thiamine pyrophosphate-bind-
ing thi box and the glucosamine-6-phosphate-binding glmS
ribozyme-riboswitch (Edwards et al., 2007), the tetracycline
aptamer employs magnesium ion as a molecular handle to aug-
ment its ligand and recognize it indirectly. Although this mecha-
nism is clearly advantageous for a negatively charged nucleic
acid to bind to phosphate-containing metabolites, or the anionic
ketoenolate moiety of tetracycline, natural riboswitches have
evolved to function by recognizing neutral ligands such as gua-
nine or adenine, or positively charged effectors such as S-ad-
enosylmethionine. Thus, the use of chelated magnesium ions
for recognition of effectors does not appear to be a requirement
for in vivo function. Third, the overall architecture of the tetracy-
cline riboswitch is reminiscent of that of several natural ribos-
witches in that it is composed of two helical stacks that pack
together using long-range interactions, and cradle the ligand in
their interface. A correlate of this architecture is the folding of
some RNA regions concomitant with ligand binding. Thus, the
purine riboswitch has an h-shaped architecture, harbors its li-
gand at the junction of three helices, and the binding reaction
is strongly unfavorable entropically (Gilbert et al., 2006). Crystal-
lographic analysis of the thi box (another h-shaped riboswitch)
binding to ligands that span a 5000-fold range in affinity demon-
strated progressive ordering of parts of the RNA with increasing
affinity (Edwards and Ferre´-D’Amare´, 2006). Blouin and Lafon-
taine (2007) have shown that a ligand binding-induced long-
range loop-loop interaction of the lysine riboswitch is important
for lysine-induced transcription termination. Thus, it is likely
that the overall architecture and the ligand-induced local folding
of the tetracycline riboswitch are important aspects of its ability
to regulate gene expression in vivo.
SIGNIFICANCE
The tetracycline aptamer is unusual among in vitro selected
small-molecule-binding RNAs because of its high affinity for
its ligand, its three-helix junction architecture, and its ability
to function as an artificial riboswitch. The crystal structure of
the aptamer bound to 7-chlorotetracycline reveals a com-
posite binding site at the junction of the two helical stacks
of the h-shaped RNA. The aptamer appears to achieve
high affinity and specificity by augmenting the antibiotic
with a chelated magnesium ion, and by employing a binding
site that does not rely exclusively on nucleobase stacking
with the aromatic and conjugated rings of the antibiotic. In
this, the binding site of the aptamer resembles that of the
TetR protein (which binds tetracycline with an affinity similar
to that of the aptamer). Interpretation of the results of previ-
ous biochemical and calorimetric analyses (Berens et al.,
2001; Hanson et al., 2005) in light of our crystal structure sug-
gests that localized folding of the binding site, and concom-
itant ordering of buried solvent and hydrated magnesium
ions, accompanies antibiotic binding. This localized folding,
and an overall h-shaped architecture stabilized by long-
range interactions, make the tetracycline aptamer more
similar to naturally occurring riboswitches, rather than to
typical small-molecule-binding aptamers. The latter usually
have simpler structures consisting of two stacked helices,Chemistry & Biology 15, 1125–1and undergo large folding transitions upon binding their
cognate ligand (Feigon et al., 1996; Hermann and Patel,
2000; Wilson and Szostak, 1999).
EXPERIMENTAL PROCEDURES
RNA and Protein Preparation
RNA was transcribed in vitro with T7 RNA polymerase from double-stranded
DNA templates. These were generated by PCR using a 30 primer containing
two 20-OMe nucleotides at its 50 end to reduce 30 heterogeneity of runoff tran-
scripts (Kao et al., 1999). Transcription reactions (310K, 2 hr) contained
1/10 volume of PCR reaction, 30 mM Tris-HCl (pH 8.1), 30 mM MgCl2,
0.01% (v/v) Triton X-100, 2 mM spermidine hydrochloride, 5 mM each of the
four NTPs, 1 mM DTT, and 0.05 g/l T7 RNA polymerase. Reactions also con-
tained 1 unit/ml of Escherichia coli inorganic pyrophosphatase (Sigma) to in-
crease RNA yield (Rupert and Ferre´-D’Amare´, 2004). RNA was purified by
denaturing PAGE, passively eluted into water, washed with 1 M KCl, desalted
and concentrated by ultrafiltration, and stored at 277K. Selenomethionyl U1A-
RBD double mutant preparation has been described (Ferre´-D’Amare´ and
Doudna, 2000a). The competition binding assay (Figure S1) was performed un-
der conditions described by Mu¨ller et al. (2006).
Crystallization and Diffraction Data Collection
A solution comprising 0.3 mM RNA, 0.33 mM selenomethionyl U1A-RBD dou-
ble mutant, 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 0.5 mM 7-chlorotetracy-
cline, and 0.25 mM spermine hydrochloride was incubated for 20 min at
310K. Drops prepared by mixing 1 ml each of this solution and a reservoir so-
lution comprising 50 mM HEPES-KOH (pH 7.0), 20 mM MgCl2, and
12.5%–15% (w/v) PEG 8000 were equilibrated by vapor diffusion at 296K in
the dark. Cube-shaped crystals with the symmetry of space group P4212
(a = 120.84 A˚; c = 55.28 A˚; one RNA-U1A-chlorotetracycline complex per
asymmetric unit) appeared within 4 weeks and grew over the course of 2 ad-
ditional weeks tomaximum dimensions of 0.15mm3. Crystals were transferred
over the course of 10–15 min to a solution comprising 50 mM HEPES-KOH
(pH 7.0), 20 mMMgCl2, 15% (w/v) PEG 8000, 0.5 mM spermine hydrochloride,
0.5 mM 7-chlorotetracycline, and 30% (v/v) glycerol, mounted on nylon loops,
and flash-frozen by plunging into liquid nitrogen. Three-energyMAD diffraction
data were collected from a single crystal at beamline 5.0.2 of the Advanced
Light Source (ALS, Lawrence Berkeley National Laboratory) and reduced
with the HKL package (Otwinowski and Minor, 1997). Crystallographic statis-
tics appear in Table 1.
Structure Determination and Refinement
Three selenium sites were located using the program SOLVE (Terwilliger and
Berendzen, 1999). Heavy-atom parameters were refined, phases were calcu-
lated, and density modification was performed using the program CNS
(Bru¨nger et al., 1998). The resulting experimental electron density map was
of excellent quality (Figure 5C) and allowed unambiguous building of the
RNA, protein, and most of the RNA-bound magnesium ions and their coordi-
nation waters using the programO (Jones et al., 1991). Although clear electron
density for the antibiotic was present, it was not included in the crystallo-
graphicmodel until near the end of refinement. Rounds of simulated annealing,
energy minimization, and restrained isotropic atomic temperature factor
refinement using a maximum-likelihood target with experimental phase prob-
ability distributions in CNS produced a model with Rfree = 28.2%. The 7-chlor-
otetracycline was then placed into the residual electron density (Figure 3C),
and final rounds of refinement were carried out with REFMAC (Murshudov
et al., 1997) using a maximum-likelihood target and no TLS refinement (Fig-
ure S4). The final model comprises all RNA residues, U1A RBD residues
6–95, one 7-chlorotetracycline, 12 magnesium ions, and 146 water molecules.
The b and g phosphates of the 50-triphosphate of the RNA lack electron den-
sity, are presumed disordered, and are not included in the crystallographic
model. Refinement statistics appear in Table 1. Solvent accessibility was cal-
culated with CNS, using a probe radius of 1.4 A˚. Figures were prepared with
Ribbons (Carson, 1997) and GRASP (Nicholls et al., 1993).137, October 20, 2008 ª2008 Elsevier Ltd All rights reserved 1135
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Atomic coordinates and structure factor amplitudes of the tetracycline ap-
tamer RNA in complex with 7-chlorotetracycline and the U1A RBD have
been deposited in the Protein Data Bank under ID code 3EGZ.
SUPPLEMENTAL DATA
Supplemental Data include four figures and Supplemental References and can
be found with this article online at http://www.chembiol.com/cgi/content/full/
15/10/1125/DC1/.
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